Thus, the assessment of both NE and PR3 activity would allow the investigation of drug specificity and any synergistic effect, especially as evidence suggests that PR3 may play a greater role in driving emphysema generation than that attributed historically to NE alone (Korkmaz et al., 2005; Sinden et al., 2015). The gene discussed is PRTN3; the disease is pulmonary emphysema.